Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed7

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT00001623Not ApplicableCompleted
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Graft vs Host DiseaseHematologic NeoplasmLeukemia+2 more
Principalinvestigator
NCT00001637Phase 2Completed
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
Principalinvestigator
NCT00001872Completed
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Graft vs Host DiseaseHematologic Neoplasm
Principalinvestigator
NCT00001873Phase 2Completed
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
Principalinvestigator
NCT00061581Phase 2Completed
Experimental Bone Marrow Transplant Protocol
Acute Lymphocytic LeukemiaAcute Myelocytic LeukemiaChronic Myeloid Leukemia+2 more
Principalinvestigator
NCT00353821Completed
Investigating Cytokine Genes of Stem Cell Donors
Stem Cell Transplantation
Principalinvestigator
NCT00353860Phase 2Completed
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
ImmunosuppressionLeukemia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+6 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score21%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsGraft vs Host DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+6 more
Similarity Score21%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+5 more
Similarity Score18%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more
Similarity Score14%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+3 more
Similarity Score14%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsGraft vs Host Disease+2 more
Similarity Score12%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+2 more
Similarity Score12%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score12%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

LeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-CellGraft vs Host Disease+1 more

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00001623Not ApplicablePrincipalInvestigator

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

Graft vs Host DiseaseHematologic NeoplasmLeukemia+2 more
Completed
NCT00001637Phase 2PrincipalInvestigator

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
Completed
NCT00001872PrincipalInvestigator

Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

Graft vs Host DiseaseHematologic Neoplasm
Completed
NCT00001873Phase 2PrincipalInvestigator

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
Completed
NCT00061581Phase 2PrincipalInvestigator

Experimental Bone Marrow Transplant Protocol

Acute Lymphocytic LeukemiaAcute Myelocytic LeukemiaChronic Myeloid Leukemia+2 more
Completed
NCT00353821PrincipalInvestigator

Investigating Cytokine Genes of Stem Cell Donors

Stem Cell Transplantation
Completed
NCT00353860Phase 2PrincipalInvestigator

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

ImmunosuppressionLeukemia
Completed

All 7 trials loaded